Research and Markets: Antibodies in Oncology Drug Pipeline Update 2013 ... The Herald | HeraldOnline.com The commercial and therapeutic success of antibodies like Rituxan, Avastin, and Erbitux will force the industry to look into the next generation of therapeutic antibodies. There are today 306 companies plus partners developing 634 antibody drugs in ... |
